Oxidative lipidomics coming of age: Advances in analysis of oxidized phospholipids in physiology and pathology

Antioxidants and Redox Signaling

Volumn 22, Issue 18, 2015, Pages 1646-1666

  Spickett, Corinne M ^a   Pitt, Andrew R ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARDIOLIPIN; FATTY ACID; GOLD NANOPARTICLE; HYDROPEROXIDE; HYDROXIDE; LYSOPHOSPHATIDYLCHOLINE; OXIDIZED PHOSPHOLIPID; PHOSPHATIDIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLGLYCEROL; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; PHOSPHOLIPID; SPHINGOMYELIN; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ALCOHOL LIVER DISEASE; ATHEROSCLEROSIS; CYSTIC FIBROSIS; DATA ANALYSIS SOFTWARE; DATA BASE; ELECTROSPRAY MASS SPECTROMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY ACID OXIDATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFLAMMATORY DISEASE; LEPROSY; LIPID ANALYSIS; LIPID OXIDATION; LIPIDOMICS; MASS FRAGMENTOGRAPHY; MASS SPECTROMETER; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSIOLOGICAL PROCESS; PNEUMONIA; PRECURSOR; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REVERSED PHASE LIQUID CHROMATOGRAPHY; REVIEW; SIGNAL NOISE RATIO; SUPERCRITICAL FLUID CHROMATOGRAPHY; ANIMAL; CHEMISTRY; INFLAMMATION; LIPID METABOLISM; METABOLISM; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOLOGY;

ANIMALIA;

ANIMALS; BIOMARKERS; HUMANS; INFLAMMATION; LIPID METABOLISM; MASS SPECTROMETRY; OXIDATION-REDUCTION; OXIDATIVE STRESS; PHOSPHOLIPIDS;

EID: 84930677412     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2014.6098     Document Type: Review

References (154)

1. Adachi J, Yoshioka N, Funae R, Nushida H, Asano M, and Ueno Y. Determination of phosphatidylcholine monohydroperoxides using quadrupole time-of-flight mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 806: 41-46, 2004.
2. Baker PR, Armando AM, Campbell JL, Quehenberger O, and Dennis EA. Three-dimensional enhanced lipidomics analysis combining UPLC, differential ion mobility spectrometry, and mass spectrometric separation strategies. J Lipid Res 55: 2432-2442, 2014.
3. Baker PR, Lin Y, Schopfer FJ, Woodcock SR, Groeger AL, Batthyany C, Sweeney S, Long MH, Iles KE, Baker LM, Branchaud BP, Chen YE, and Freeman BA. Fatty acid transduction of nitric oxide signaling: multiple nitrated unsaturated fatty acid derivatives exist in human blood and urine and serve as endogenous peroxisome proliferator-activated receptor ligands. J Biol Chem 280: 42464-42475, 2005.
4. Banerjee S and Mazumdar S. Electrospray ionization mass spectrometry: a technique to access the information beyond the molecular weight of the analyte. Int J Anal Chem 2012: 282574, 2012.
5. Bayir H, Tyurin VA, Tyurina YY, Viner R, Ritov V, Amoscato AA, Zhao Q, Zhang XJ, Janesko-Feldman KL, Alexander H, Basova LV, Clark RS, Kochanek PM, and Kagan VE. Selective early cardiolipin peroxidation after traumatic brain injury: an oxidative lipidomics analysis. Ann Neurol 62: 154-169, 2007.
6. Benabdellah F, Seyer A, Quinton L, Touboul D, Brunelle A, and Laprevote O. Mass spectrometry imaging of rat brain sections: nanomolar sensitivity with MALDI versus nanometer resolution by TOF-SIMS. Anal Bioanal Chem 396: 151-162, 2010.
7. Bochkov VN, Oskolkova OV, Birukov KG, Levonen AL, Binder CJ, and Stockl J. Generation and biological activities of oxidized phospholipids. Antioxid Redox Signal 12: 1009-1059, 2010.
8. Breusing N, Grune T, Andrisic L, Atalay M, Bartosz G, Biasi F, Borovic S, Bravo L, Casals I, Casillas R, Dinischiotu A, Drzewinska J, Faber H, Fauzi NM, Gajewska A, Gambini J, Gradinaru D, Kokkola T, Lojek A, Luczaj W, Margina D, Mascia C, Mateos R, Meinitzer A, Mitjavila MT, Mrakovcic L, Munteanu MC, Podborska M, Poli G, Sicinska P, Skrzydlewska E, Vina J, Wiswedel I, Zarkovic N, Zelzer S, and Spickett CM. An inter-laboratory validation of methods of lipid peroxidation measurement in UVA-treated human plasma samples. Free Radic Res 44: 1203-1215, 2010.
9. Brouwers JF. Liquid chromatographic-mass spectrometric analysis of phospholipids. Chromatography, ionization and quantification. Biochim Biophys Acta 1811: 763-775, 2011.
10. Brown SH, Huxtable LH, Willcox MD, Blanksby SJ, and Mitchell TW. Automated surface sampling of lipids from worn contact lenses coupled with tandem mass spectrometry. Analyst 138: 1316-1320, 2013.
11. Cajka T and Fiehn O. Comprehensive analysis of lipids in biological systems by liquid chromatography-mass spectrometry. Trends Analyt Chem 61: 192-206, 2014.
12. Calder PC. Polyunsaturated fatty acids and inflammation. Prostaglandins Leukot Essent Fatty Acids 75: 197-202, 2006.
13. Camont L, Lhomme M, Rached F, Le Goff W, Negre- Salvayre A, Salvayre R, Calzada C, Lagarde M, Chapman MJ, and Kontush A. Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities. Arterioscler Thromb Vasc Biol 33: 2715-2723, 2013.
14. Castro-Perez J, Roddy TP, Nibbering NM, Shah V, McLaren DG, Previs S, Attygalle AB, Herath K, Chen Z, Wang SP, Mitnaul L, Hubbard BK, Vreeken RJ, Johns DG, and Hankemeier T. Localization of fatty acyl and double bond positions in phosphatidylcholines using a dual stage CID fragmentation coupled with ion mobility mass spectrometry. J Am Soc Mass Spectrom 22: 1552- 1567, 2011.
15. Choi BK, Hercules DM, Zhang TL, and Gusev AI. Comparison of quadrupole, time-of-flight and Fourier transform mass analyzers for LC-MS applications. Spectroscopy 18: S24- + , 2003.
16. Chughtai K, Jiang L, Greenwood TR, Glunde K, and Heeren RM. Mass spectrometry images acylcarnitines, phosphatidylcholines, and sphingomyelin in MDA-MB- 231 breast tumor models. J Lipid Res 54: 333-344, 2013.
17. Cracowski JL, Baguet JP, Ormezzano O, Bessard J, Stanke-Labesque F, Bessard G, and Mallion JM. Lipid peroxidation is not increased in patients with untreated mild-to-moderate hypertension. Hypertension 41: 286-288, 2003.
18. Cruz D, Watson AD, Miller CS, Montoya D, Ochoa MT, Sieling PA, Gutierrez MA, Navab M, Reddy ST, Witztum JL, Fogelman AM, Rea TH, Eisenberg D, Berliner J, and Modlin RL. Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy. J Clin Invest 118: 2917-2928, 2008.
19. Dasilva G, Pazos M, Gallardo JM, Rodriguez I, Cela R, and Medina I. Lipidomic analysis of polyunsaturated fatty acids and their oxygenated metabolites in plasma by solidphase extraction followed by LC-MS. Anal Bioanal Chem 406: 2827-2839, 2014.
20. Domingues MR, Reis A, and Domingues P. Mass spectrometry analysis of oxidized phospholipids. Chem Phys Lipids 156: 1-12, 2008.
21. Donovan EL, Pettine SM, Hickey MS, Hamilton KL, and Miller BF. Lipidomic analysis of human plasma reveals ether-linked lipids that are elevated in morbidly obese humans compared to lean. Diabetol Metab Syndr 5, 24, 2013.
22. Edelstein C, Pfaffinger D, Yang M, Hill JS, and Scanu AM. Naturally occurring human plasminogen, like genetically related apolipoprotein(a), contains oxidized phosphatidylcholine adducts. Biochim Biophys Acta Mol Cell Biol Lipids 1801: 738-745, 2010.
23. El-Aneed A, Cohen A, and Banoub J. Mass spectrometry, review of the basics: electrospray, MALDI, and commonly used mass analyzers. Appl Spectrosc Rev 44: 210-230, 2009.
24. Ellis SR, Brown SH, In Het Panhuis M, Blanksby SJ, and Mitchell TW. Surface analysis of lipids by mass spectrometry: more than just imaging. Prog Lipid Res 52: 329- 353, 2013.
25. Fedorova M, Bollineni RC, and Hoffmann R. Protein carbonylation as a major hallmark of oxidative damage: Update of analytical strategies. Mass Spectrom Rev 33: 79-97, 2014.
26. Flemmig J and Arnhold J. Interaction of hypochlorous acid and myeloperoxidase with phosphatidylserine in the presence of ammonium ions. J Inorg Biochem 104: 759- 764, 2010.
27. Flemmig J, Spalteholz H, Schubert K, Meier S, and Arnhold J. Modification of phosphatidylserine by hypochlorous acid. Chem Phys Lipids 161: 44-50, 2009.
28. Foster JM, Moreno P, Fabregat A, Hermjakob H, Steinbeck C, Apweiler R, Wakelam MJ, and Vizcaino JA. LipidHome: a database of theoretical lipids optimized for high throughput mass spectrometry lipidomics. PLoS One 8: e61951, 2013.
29. Friedman P, Horkko S, Steinberg D, Witztum JL, and Dennis EA. Correlation of antiphospholipid antibody recognition with the structure of synthetic oxidized phospholipids - Importance of Schiff base formation and aldol condensation. J Biol Chem 277: 7010-7020, 2002.
30. Fruhwirth GO, Loidl A, and Hermetter A. Oxidized phospholipids: from molecular properties to disease. Biochim Biophys Acta 1772: 718-736, 2007.
31. Fu PF and Birukov KG. Oxidized phospholipids in control of inflammation and endothelial barrier. Transl Res 153: 166-176, 2009.
32. Fuchs B, Bresler K, and Schiller J. Oxidative changes of lipids monitored by MALDI MS. Chem Phys Lipids 164: 782-795, 2011.
33. Fuchs B, Suss R, and Schiller J. An update of MALDITOF mass spectrometry in lipid research. Prog Lipid Res 49: 450-475, 2010.
34. Garrett TJ and Yost RA. Analysis of intact tissue by intermediate- pressure MALDI on a linear ion trap mass spectrometer. Anal Chem 78: 2465-2469, 2006.
35. Gode D and Volmer DA. Lipid imaging by mass spectrometry- a review. Analyst 138: 1289-1315, 2013.
36. Goto-Inoue N, Hayasaka T, Zaima N, and Setou M. Imaging mass spectrometry for lipidomics. Biochim Biophys Acta 1811: 961-969, 2011.
37. Greenberg ME, Li XM, Gugiu BG, Gu X, Qin J, Salomon RG, and Hazen SL. The lipid whisker model of the structure of oxidized cell membranes. J Biol Chem 283: 2385-2396, 2008.
38. Greig FH, Kennedy S, and Spickett CM. Physiological effects of oxidized phospholipids and their cellular signaling mechanisms in inflammation. Free Radic Biol Med 52: 266-280, 2012.
39. Gross JH. Mass Spectrometry: A Textbook. Berlin; London: Springer, 2004.
40. Gruber F, Bicker W, Oskolkova OV, Tschachler E, and Bochkov VN. A simplified procedure for semi-targeted lipidomic analysis of oxidized phosphatidylcholines induced by UVA irradiation. J Lipid Res 53: 1232-1242, 2012.
41. Haller E, Stubiger G, Lafitte D, Lindner W, and Lammerhofer M. Chemical recognition of oxidation-specific epitopes in low-density lipoproteins by a nanoparticle based concept for trapping, enrichment, and liquid chromatography- tandem mass spectrometry analysis of oxidative stress biomarkers. Anal Chem 86: 9954-9961, 2014.
42. Hammond VJ, Morgan AH, Lauder S, Thomas CP, Brown S, Freeman BA, Lloyd CM, Davies J, Bush A, Levonen AL, Kansanen E, Villacorta L, Chen YE, Porter N, Garcia- Diaz YM, Schopfer FJ, and O'Donnell VB. Novel keto-phospholipids are generated by monocytes and macrophages, detected in cystic fibrosis, and activate peroxisome proliferator-activated receptor-gamma. J Biol Chem 287: 41651-41666, 2012.
43. Han XL, Yang K, and Gross RW. Multi-dimensional mass spectrometry-based shotgun lipidomics and novel strategies for lipidomic analyses. Mass Spectrom Rev 31: 134- 178, 2012.
44. Harron AF, Hoang K, and McEwen CN. High mass resolution tissue imaging at atmospheric pressure using laserspray ionization mass spectrometry. Int J Mass Spectrom 352: 65-69, 2013.
45. Hartler J, Tharakan R, Kofeler HC, Graham DR, and Thallinger GG. Bioinformatics tools and challenges in structural analysis of lipidomics MS/MS data. Brief Bioinform 14: 375-390, 2013.
46. Hinterwirth H, Stubiger G, Lindner W, and Lammerhofer M. Gold nanoparticle-conjugated anti-oxidized lowdensity lipoprotein antibodies for targeted lipidomics of oxidative stress biomarkers. Anal Chem 85: 8376-8384, 2013.
47. Hoene M, Li J, Haring HU, Weigert C, Xu G, and Lehmann R. The lipid profile of brown adipose tissue is sexspecific in mice. Biochim Biophys Acta 1842: 1563-1570, 2014.
48. Hoff HF, O'Neil J, Wu ZP, Hoppe G, and Salomon RL. Phospholipid hydroxyalkenals - Biological and chemical properties of specific oxidized lipids present in atherosclerotic lesions. Arterioscl Thromb Vasc Biol 23: 275-282, 2003.
49. Hui SP, Chiba H, Jin S, Nagasaka H, and Kurosawa T. Analyses for phosphatidylcholine hydroperoxides by LC/ MS. J Chromatogr B Analyt Technol Biomed Life Sci 878: 1677-1682, 2010.
50. Hui SP, Taguchi Y, Takeda S, Ohkawa F, Sakurai T, Yamaki S, Jin S, Fuda H, Kurosawa T, and Chiba H. Quantitative determination of phosphatidylcholine hydroperoxides during copper oxidation of LDL and HDL by liquid chromatography/mass spectrometry. Anal Bioanal Chem 403: 1831-1840, 2012.
51. Jackson SN, Barbacci D, Egan T, Lewis EK, Schultz JA, and Woods AS. MALDI-ion mobility mass spectrometry of lipids in negative ion mode. Anal Methods 6: 5001- 5007, 2014.
52. Jackson SN, Ugarov M, Egan T, Post JD, Langlais D, Albert Schultz J, and Woods AS. MALDI-ion mobility- TOFMS imaging of lipids in rat brain tissue. J Mass Spectrom 42: 1093-1098, 2007.
53. Jerlich A, Pitt AR, Schaur RJ, and Spickett CM. Pathways of phospholipid oxidation by HOCl in human LDL detected by LC-MS. Free Radic Biol Med 28: 673-682, 2000.
54. Jessup W, Dean RT, and Gebicki JM. Iodometric Determination of Hydroperoxides in Lipids and Proteins. Oxygen Radic Biol Syst Pt C 233: 289-303, 1994.
55. Kanai Y, Hiroki S, Koshino H, Konoki K, Cho Y, Cayme M, Fukuyo Y, and Yotsu-Yamashita M. Identification of novel oxidized levuglandin D-2 in marine red alga and mouse tissue. J Lipid Res 52: 2245-2254, 2011.
56. Kliman M, May JC, and McLean JA. Lipid analysis and lipidomics by structurally selective ion mobility-mass spectrometry. Biochim Biophys Acta 1811: 935-945, 2011.
57. Kofeler HC, Fauland A, Rechberger GN, and Trotzmuller M. Mass spectrometry based lipidomics: an overview of technological platforms. Metabolites 2: 19-38, 2012.
58. Lam SM and Shui GH. Lipidomics as a principal tool for advancing biomedical research. J Genet Genom 40: 375- 390, 2013.
59. Le Faouder P, Baillif V, Spreadbury I, Motta JP, Rousset P, Chene G, Guigne C, Terce F, Vanner S, Vergnolle N, Bertrand-Michel J, Dubourdeau M, and Cenac N. LC-MS/ MS method for rapid and concomitant quantification of pro-inflammatory and pro-resolving polyunsaturated fatty acid metabolites. J Chromatogr B Analyt Technol Biomed Life Sci 932: 123-133, 2013.
60. Lee JY, Lim S, Park S, and Moon MH. Characterization of oxidized phospholipids in oxidatively modified low density lipoproteins by nanoflow liquid chromatographytandem mass spectrometry. J Chromatogr A 1288: 54-62, 2013.
61. Leitinger N. The role of phospholipid oxidation products in inflammatory and autoimmune diseases: evidence from animal models and in humans. Subcell Biochem 49: 325-350, 2008.
62. Lesnefsky EJ, Minkler P, and Hoppel CL. Enhanced modification of cardiolipin during ischemia in the aged heart. J Mol Cell Cardiol 46: 1008-1015, 2009.
63. Li P, Tong Y, Yang H, Zhou S, Xiong F, Huo T, and Mao M. Mitochondrial translocation of human telomerase reverse transcriptase in cord blood mononuclear cells of newborns with gestational diabetes mellitus mothers. Diabetes Res Clin Pract 103: 310-318, 2014.
64. Lim S, Byeon SK, Lee JY, and Moon MH. Computational approach to structural identification of phospholipids using raw mass spectra from nanoflow liquid chromatography- electrospray ionization-tandem mass spectrometry. J Mass Spectrom 47: 1004-1014, 2012.
65. Lima ES, Di Mascio P, Rubbo H, and Abdalla DS. Characterization of linoleic acid nitration in human blood plasma by mass spectrometry. Biochemistry 41: 10717-10722, 2002.
66. Lintonen TP, Baker PR, Suoniemi M, Ubhi BK, Koistinen KM, Duchoslav E, Campbell JL, and Ekroos K. Differential mobility spectrometry-driven shotgun lipidomics. Anal Chem 86: 9662-9669, 2014.
67. Liu W, Morrow JD, and Yin HY. Quantification of F-2- isoprostanes as a reliable index of oxidative stress in vivo using gas chromatography-mass spectrometry (GC-MS) method. Free Radic Biol Med 47: 1101-1107, 2009.
68. Liu W, Porter NA, Schneider C, Brash AR, and Yin HY. Formation of 4-hydroxynonenal from cardiolipin oxidation: Intramolecular peroxyl radical addition and decomposition. Free Radic Biol Med 50: 166-178, 2011.
69. Maccarone AT, Duldig J, Mitchell TW, Blanksby SJ, Duchoslav E, and Campbell JL. Characterization of acyl chain position in unsaturated phosphatidylcholines using differential mobility-mass spectrometry. J Lipid Res 55: 1668-1677, 2014.
70. Maciel E, da Silva RN, Simoes C, Domingues P, and Domingues MR. Structural characterization of oxidized glycerophosphatidylserine: evidence of polar head oxidation. J Am Soc Mass Spectrom 22: 1804-1814, 2011.
71. Maciel E, da Silva RN, Simoes C, Melo T, Ferreira R, Domingues P, and Domingues MR. Liquid chromatography- tandem mass spectrometry of phosphatidylserine advanced glycated end products. Chem Phys Lipids 174: 1-7, 2013.
72. Maciel E, Neves BM, Santinha D, Reis A, Domingues P, Teresa Cruz M, Pitt AR, Spickett CM, and Domingues MR. Detection of phosphatidylserine with a modified polar head group in human keratinocytes exposed to the radical generator AAPH. Arch Biochem Biophys 548: 38-45, 2014.
73. Martin-Venegas R, Jauregui O, and Moreno JJ. Liquid chromatography-tandem mass spectrometry analysis of eicosanoids and related compounds in cell models. J Chromatogr B Analyt Technol Biomed Life Sci 964: 41-49, 2014.
74. Maskrey BH, Bermudez-Fajardo A, Morgan AH, Stewart- Jones E, Dioszeghy V, Taylor GW, Baker PR, Coles B, Coffey MJ, Kuhn H, and O'Donnell VB. Activated platelets and monocytes generate four hydroxyphosphatidylethanolamines via lipoxygenase. J Biol Chem 282: 20151-20163, 2007.
75. Massey KA and Nicolaou A. Lipidomics of polyunsaturated- fatty-acid-derived oxygenated metabolites. Biochem Soc Trans 39: 1240-1246, 2011.
76. Matot I, Manevich Y, Al-Mehdi AB, Song C, and Fisher AB. Fluorescence imaging of lipid peroxidation in isolated rat lungs during nonhypoxic lung ischemia. Free Radic Biol Med 34: 785-790, 2003.
77. Megli FM, Russo L, and Conte E. Spin labeling EPR studies of the properties of oxidized phospholipid-containing lipid vesicles. Biochim Biophys Acta Biomembranes 1788: 371-379, 2009.
78. Messner MC, Albert CJ, Hsu FF, and Ford DA. Selective plasmenylcholine oxidation by hypochlorous acid: formation of lysophosphatidylcholine chlorohydrins. Chem Phys Lipids 144: 34-44, 2006.
79. Milne GL, Gao B, Terry ES, Zackert WE, and Sanchez SC. Measurement of F2- isoprostanes and isofurans using gas chromatography-mass spectrometry. Free Radic Biol Med 59: 36-44, 2013.
80. Miyazawa T, Fujimoto K, Suzuki T, and Yasuda K. Determination of phospholipid hydroperoxides using luminol chemiluminescence-high-performance liquid chromatography. Methods Enzymol 233: 324-332, 1994.
81. Moore K and Roberts LJ, 2nd. Measurement of lipid peroxidation. Free Radic Res 28: 659-671, 1998.
82. Morgan AH, Hammond VJ, Morgan L, Thomas CP, Tallman KA, Garcia-Diaz YR, McGuigan C, Serpi M, Porter NA, Murphy RC, and O'Donnell VB. Quantitative assays for esterified oxylipins generated by immune cells. Nat Protoc 5: 1919-1931, 2010.
83. Mubiru E, Shrestha K, Papastergiadis A, and De Meulenaer B. Improved gas chromatography-flame ionization detector analytical method for the analysis of epoxy fatty acids. J Chromatogr A 1318: 217-225, 2013.
84. Murphy RC, Leiker TJ, and Barkley RM. Glycerolipid and cholesterol ester analyses in biological samples by mass spectrometry. Biochim Biophys Acta Mol Cell Biol Lipids 1811: 776-783, 2011.
85. Nakanishi H, Iida Y, Shimizu T, and Taguchi R. Analysis of oxidized phosphatidylcholines as markers for oxidative stress, using multiple reaction monitoring with theoretically expanded data sets with reversed-phase liquid chromatography/tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 877: 1366-1374, 2009.
86. Nemes P, Woods AS, and Vertes A. Simultaneous imaging of small metabolites and lipids in rat brain tissues at atmospheric pressure by laser ablation electrospray ionization mass spectrometry. Anal Chem 82: 982-988, 2010.
87. Niki E. Lipid peroxidation: physiological levels and dual biological effects. Free Radic Biol Med 47: 469-484, 2009.
88. Norris JL and Caprioli RM. Analysis of tissue specimens by matrix-assisted laser desorption/ionization imaging mass spectrometry in biological and clinical research. Chem Rev 113: 2309-2342, 2013.
89. O'Donnell VB and Murphy RC. New families of bioactive oxidized phospholipids generated by immune cells: identification and signaling actions. Blood 120: 1985- 1992, 2012.
90. O'Donnell VB, Murphy RC, and Watson SP. Platelet lipidomics: modern day perspective on lipid discovery and characterization in platelets.Circ Res 114: 1185-1203, 2014.
91. Paradies G, Ruggiero FM, Petrosillo G, and Quagliariello E. Peroxidative damage to cardiac mitochondria: cytochrome oxidase and cardiolipin alterations. Febs Lett 424: 155-158, 1998.
92. Pitt AR and Spickett CM. Mass spectrometric analysis of HOCl- and free-radical-induced damage to lipids and proteins. Biochem Soc Trans 36: 1077-1082, 2008.
93. Prasain JK, Arabshahi A, Taub PR, Sweeney S, Moore R, Sharer JD, and Barnes S. Simultaneous quantification of F2-isoprostanes and prostaglandins in human urine by liquid chromatography tandem-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 913-914: 161-168, 2013.
94. Pryor WA and Porter NA. Suggested mechanisms for the production of 4-hydroxy-2-nonenal from the autoxidation of polyunsaturated fatty acids. Free Radic Biol Med 8: 541-543, 1990.
95. Pulfer M and Murphy RC. Electrospray mass spectrometry of phospholipids. Mass Spectrom Rev 22: 332-364, 2003.
96. Purwaha P, Gu Y, Kelavkar U, Kang JX, Law B, Wu EX, and Qian SY. LC/ESR/MS study of pH-dependent radical generation from 15-LOX-catalyzed DPA peroxidation. Free Radic Bio Med 51: 1461-1470, 2011.
97. Ravandi A, Babaei S, Leung R, Monge JC, Hoppe G, Hoff H, Kamido H, and Kuksis A. Phospholipids and oxophospholipids in atherosclerotic plaques at different stages of plaque development. Lipids 39: 97-109, 2004.
98. Ravandi A, Leibundgut G, Hung MY, Patel M, Hutchins PM, Murphy RC, Prasad A, Mahmud E, Miller YI, Dennis EA, Witztum JL, and Tsimikas S. Release and capture of bioactive oxidized phospholipids and oxidized cholesteryl esters during percutaneous coronary and peripheral arterial interventions in humans. J Am Coll Cardiol 63: 1961- 1971, 2014.
99. Reis A, Domingues P, and Domingues MR. Structural motifs in primary oxidation products of palmitoyl-arachidonoyl- phosphatidylcholines by LC-MS/MS. J Mass Spectrom 48: 1207-1216, 2013.
100. Reis A, Rudnitskaya A, Blackburn GJ, Mohd Fauzi N, Pitt AR, and Spickett CM. A comparison of five lipid extraction solvent systems for lipidomic studies of human LDL. J Lipid Res 54: 1812-1824, 2013.
101. Reis A, Rudnitskaya A, Chariyavilaskul P, Dhaun N, Melville V, Goddard J, Webb DJ, Pitt AR, and Spickett CM. Top-down lipidomics of low density lipoprotein reveal altered lipid profiles in advanced chronic kidney disease. J Lipid Res 56: 413-422, 2015.
102. Reis A and Spickett CM. Chemistry of phospholipid oxidation. Biochim Biophys Acta 1818: 2374-2387, 2012.
103. Roberts LJ and Morrow JD. Measurement of F-2-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 28: 505-513, 2000.
104. Roberts LJ, Salomon RG, Morrow JD, and Brame CJ. New developments in the isoprostane pathway: identification of novel highly reactive gamma-ketoaldehydes (isolevuglandins) and characterization of their protein adducts. Faseb J 13: 1157-1168, 1999.
105. Salomon RG. Isolevuglandins, oxidatively truncated phospholipids, and atherosclerosis. Ann N Y Acad Sci 1043: 327-342, 2005.
106. Samhan-Arias AK, Ji J, Demidova OM, Sparvero LJ, Feng W, Tyurin V, Tyurina YY, Epperly MW, Shvedova AA, Greenberger JS, Bayir H, Kagan VE, and Amoscato AA. Oxidized phospholipids as biomarkers of tissue and cell damage with a focus on cardiolipin. Biochim Biophys Acta 1818: 2413-2423, 2012.
107. Shidoji Y, Hayashi K, Komura S, Ohishi N, and Yagi K. Loss of molecular interaction between cytochrome c and cardiolipin due to lipid peroxidation. Biochem Bioph Res Commun 264: 343-347, 1999.
108. Shimizu R, Nagai A, Tominaga H, Imura M, Onyango AN, Izumi M, Nakajima S, Tahara S, Kaneko T, and Baba N. A Combination of Molecular Probe-Tandem Electrospray Ionization Mass Spectrometry: A Technique for Tracing Structural Changes in Phospholipid Hydroperoxides. Biosci Biotech Bioch 73: 781-784, 2009.
109. Shvartsburg AA, Isaac G, Leveque N, Smith RD, and Metz TO. Separation and classification of lipids using differential ion mobility spectrometry. J Am Soc Mass Spectr 22: 1146-1155, 2011.
110. Shvedova AA, Kommineni C, Jeffries BA, Castranova V, Tyurina YY, Tyurin VA, Serbinova EA, Fabisiak JP, and Kagan VE. Redox cycling of phenol induces oxidative stress in human epidermal keratinocytes. J Invest Dermatol 114: 354-364, 2000.
111. Simons B, Kauhanen D, Sylvanne T, Tarasov K, Duchoslav E, and Ekroos K. Shotgun lipidomics by sequential precursor ion fragmentation on a hybrid quadrupole timeof- flight mass spectrometer. Metabolites 2: 195-213, 2012.
112. Spalteholz H, Wenske K, and Arnhold J. Interaction of hypohalous acids and heme peroxidases with unsaturated phosphatidylcholines. Biofactors 24: 67-76, 2005.
113. Sparvero LJ, Amoscato AA, Dixon CE, Long JB, Kochanek PM, Pitt BR, Bayir H, and Kagan VE. Mapping of phospholipids by MALDI imaging (MALDI-MSI): realities and expectations. Chem Phys Lipids 165: 545-562, 2012.
114. Sparvero LJ, Amoscato AA, Kochanek PM, Pitt BR, Kagan VE, and Bayir H. Mass-spectrometry based oxidative lipidomics and lipid imaging: applications in traumatic brain injury. J Neurochem 115: 1322-1336, 2010.
115. Spickett CM. The lipid peroxidation product 4-hydroxy-2- nonenal: Advances in chemistry and analysis. Redox Biol 1: 145-152, 2013.
116. Spickett CM and Dever G. Studies of phospholipid oxidation by electrospray mass spectrometry: from analysis in cells to biological effects. Biofactors 24: 17-31, 2005.
117. Spickett CM and Fauzi NM. Analysis of oxidized and chlorinated lipids by mass spectrometry and relevance to signalling. Biochem Soc Trans 39: 1233-1239, 2011.
118. Spickett CM, Pitt AR, and Brown AJ. Direct observation of lipid hydroperoxides in phospholipid vesicles by electrospray mass spectrometry. Free Radic Biol Med 25: 613-620, 1998.
119. Spickett CM, Reis A, and Pitt AR. Identification of oxidized phospholipids by electrospray ionization mass spectrometry and LC-MS using a QQLIT instrument. Free Radic Biol Med 51: 2133-2149, 2011.
120. Spickett CM, Wiswedel I, Siems W, Zarkovic K, and Zarkovic N. Advances in methods for the determination of biologically relevant lipid peroxidation products. Free Radic Res 44: 1172-1202, 2010.
121. Strassburg K, Huijbrechts AML, Kortekaas KA, Lindeman JH, Pedersen TL, Dane A, Berger R, Brenkman A, Hankemeier T, van Duynhoven J, Kalkhoven E, Newman JW, and Vreeken RJ. Quantitative profiling of oxylipins through comprehensive LC-MS/MS analysis: application in cardiac surgery. Anal Bioanal Chem 404: 1413-1426, 2012.
122. Stubiger G, Belgacem O, Rehulka P, Bicker W, Binder BR, and Bochkov V. Analysis of oxidized phospholipids by MALDI mass spectrometry using 6-Aza-2-thiothymine together with matrix additives and disposable target surfaces. Anal Chem 82: 5502-5510, 2010.
123. Stubiger G, Wuczkowski M, Bicker W, and Belgacem O. Nanoparticle-Based Detection of Oxidized Phospholipids by MALDI Mass Spectrometry: Nano-MALDI Approach. Anal Chem 86: 6401-6409, 2014.
124. Stutts WL, Menger RF, Kiss A, Heeren RMA, and Yost RA. Characterization of Phosphatidylcholine Oxidation Products by MALDI MSn. Anal Chem 85: 11410-11419, 2013.
125. Subbanagounder G, Deng Y, Borromeo C, Dooley AN, Berliner JA, and Salomon RG. Hydroxy alkenal phospholipids regulate inflammatory functions of endothelial cells. Vascul Pharmacol 38: 201-209, 2002.
126. Taguchi R, Houjou T, Nakanishi H, Yamazaki T, Ishida M, Imagawa M, and Shimizu T. Focused lipidomics by tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 823: 26-36, 2005.
127. Taleb A, Witztum JL, and Tsimikas S. Oxidized phospholipids on apoB-100-containing lipoproteins: a biomarker predicting cardiovascular disease and cardiovascular events. Biomark Med 5: 673-694, 2011.
128. Tam VC. Lipidomic profiling of bioactive lipids by mass spectrometry during microbial infections. Semin Immunol 25: 240-248, 2013.
129. Tam VC, Quehenberger O, Oshansky CM, Suen R, Armando AM, Treuting PM, Thomas PG, Dennis EA, and Aderem A. Lipidomic profiling of influenza infection identifies mediators that induce and resolve inflammation. Cell 154: 213-227, 2013.
130. Tsikas D and Suchy MT. Assessment of urinary F-2- isoprostanes in experimental and clinical studies: mass spectrometry versus ELISA. Hypertension 60: E14-E14, 2012.
131. Tyurin VA, Tyurina Y, Jung MY, Tungekar MA, Wasserloos KJ, Bayir H, Greenberger JS, Kochanek PM, Shvedova AA, Pitt B, and Kagan VE. Mass-spectrometric analysis of hydroperoxy- and hydroxy-derivatives of cardiolipin and phosphatidylserine in cells and tissues induced by pro-apoptotic and pro-inflammatory stimuli. J Chromatogr B 877: 2863-2872, 2009.
132. Tyurina YY, Domingues RM, Tyurin VA, Maciel E, Domingues P, Amoscato AA, Bayir H, and Kagan VE. Characterization of cardiolipins and their oxidation products by LC-MS analysis. Chem Phys Lipids 179: 3-10, 2014.
133. Tyurina YY, Kisin ER, Murray A, Tyurin VA, Kapralova VI, Sparvero LJ, Amoscato AA, Samhan-Arias AK, Swedin L, Lahesmaa R, Fadeel B, Shvedova AA, and Kagan VE. Global phospholipidomics analysis reveals selective pulmonary peroxidation profiles upon inhalation of single-walled carbon nanotubes. Acs Nano 5: 7342- 7353, 2011.
134. Tyurina YY, Poloyac SM, Tyurin VA, Kapralov AA, Jiang J, Anthonymuthu TS, Kapralova VI, Vikulina AS, Jung MY, Epperly MW, Mohammadyani D, Klein- Seetharaman J, Jackson TC, Kochanek PM, Pitt BR, Greenberger JS, Vladimirov YA, Bayir H, and Kagan VE. A mitochondrial pathway for biosynthesis of lipid mediators. Nat Chem 6: 542-552, 2014.
135. Tyurina YY, Tyurin VA, Kaynar AM, Kapralova VI, Wasserloos K, Li J, Mosher M, Wright L, Wipf P, Watkins S, Pitt BR, and Kagan VE. Oxidative lipidomics of hyperoxic acute lung injury: mass spectrometric characterization of cardiolipin and phosphatidylserine peroxidation. Am J Physiol Lung Cell Mol Physiol 299: L73-L85, 2010.
136. Uchikata T, Matsubara A, Nishiumi S, Yoshida M, Fukusaki E, and Bamba T. Development of oxidized phosphatidylcholine isomer profiling method using supercritical fluid chromatography/tandem mass spectrometry. J Chromatogr A 1250: 205-211, 2012.
137. Ungvari Z, Bailey-Downs L, Gautam T, Sosnowska D, Wang M, Monticone RE, Telljohann R, Pinto JT, de Cabo R, Sonntag WE, Lakatta EG, and Csiszar A. Age-associated vascular oxidative stress, Nrf2 dysfunction, and NF- {kappa}B activation in the nonhuman primate Macaca mulatta. J Gerontol A Biol Sci Med Sci 66: 866-875, 2011.
138. Vichi S, Cortes-Francisco N, and Caixach J. Ultrahigh resolution mass spectrometry and accurate mass measurements for high-throughput food lipids profiling. J Mass Spectrom 47: 1177-1190, 2012.
139. Wang ZY, Ciabattoni G, Creminon C, Lawson J, Fitzgerald GA, Patrono C, and Maclouf J. Immunological Characterization of Urinary 8-Epi-Prostaglandin F2-Alpha Excretion in Man. J Pharmacol Exp Ther 275: 94-100, 1995.
140. Watson AD, Leitinger N, Navab M, Faull KF, Horkko S, Witztum JL, Palinski W, Schwenke D, Salomon RG, Sha W, Subbanagounder G, Fogelman AM, and Berliner JA. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J Biol Chem 272: 13597-13607, 1997.
141. Watson AD, Subbanagounder G, Welsbie DS, Faull KF, Navab M, Jung ME, Fogelman AM, and Berliner JA. Structural identification of a novel pro-inflammatory epoxyisoprostane phospholipid in mildly oxidized low density lipoprotein. J Biol Chem 274: 24787-24798, 1999.
142. Wenk MR. Lipidomics: new tools and applications. Cell 143: 888-895, 2010.
143. Wolff SP. Ferrous ion oxidation in presence of ferric ion indicator xylenol orange for measurement of hydroperoxides. Method Enzymol 233: 182-189, 1994.
144. Woods AS and Jackson SN. The application and potential of ion mobility mass spectrometry in imaging MS with a focus on lipids. Methods Mol Biol 656: 99-111, 2010.
145. Yamada T, Uchikata T, Sakamoto S, Yokoi Y, Nishiumi S, Yoshida M, Fukusaki E, and Bamba T. Supercritical fluid chromatography/Orbitrap mass spectrometry based lipidomics platform coupled with automated lipid identification software for accurate lipid profiling. J Chromatogr A 1301: 237-242, 2013.
146. Yamamoto Y. Chemiluminescence-based high-performance liquid chromatography assay of lipid hydroperoxides. Methods Enzymol 233: 319-324, 1994.
147. Yang J, Schmelzer K, Georgi K, and Hammock BD. Quantitative profiling method for oxylipin metabolome by liquid chromatography electrospray ionization tandem mass spectrometry. Anal Chem 81: 8085-8093, 2009.
148. Yang L, Latchoumycandane C, McMullen MR, Pratt BT, Zhang R, Papouchado BG, Nagy LE, Feldstein AE, and McIntyre TM. Chronic alcohol exposure increases circulating bioactive oxidized phospholipids. J Biol Chem 285: 22211-22220, 2010.
149. Yin H, Cox BE, Liu W, Porter NA, Morrow JD, and Milne GL. Identification of intact oxidation products of glycerophospholipids in vitro and in vivo using negative ion electrospray iontrap mass spectrometry. J Mass Spectrom 44: 672-680, 2009.
150. Yoshida Y, Kodai S, Takemura S, Minamiyama Y, and Niki E. Simultaneous measurement of F2-isoprostane, hydroxyoctadecadienoic acid, hydroxyeicosatetraenoic acid, and hydroxycholesterols from physiological samples. Anal Biochem 379: 105-115, 2008.
151. Yurkova R, Huster D, and Arnhold J. Free radical fragmentation of cardiolipin by cytochrome c. Chem Phys Lipids 158: 16-21, 2009.
152. Zemski Berry KA, Turner WW, VanNieuwenhze MS, and Murphy RC. Stable isotope labeled 4-(dimethylamino)- benzoic acid derivatives of glycerophosphoethanolamine lipids. Anal Chem 81: 6633-6640, 2009.
153. Zemski Berry KA, Turner WW, VanNieuwenhze MS, and Murphy RC. Characterization of oxidized phosphatidylethanolamine derived from RAW 264.7 cells using 4- (dimethylamino)benzoic acid derivatives. Eur J Mass Spectrom (Chichester, Eng) 16: 463-470, 2010.
154. Zivkovic AM, Yang J, Georgi K, Hegedus C, Nording ML, O'Sullivan A, German JB, Hogg RJ, Weiss RH, Bay C, and Hammock BD. Serum oxylipin profiles in IgA nephropathy patients reflect kidney functional alterations. Metabolomics 8: 1102-1113, 2012.